Ravindra Kumar is CSO & VP at ACCELERON PHARMA INC (XLRN). They have made 1 open-market trade across 1 company since 2014, most recently 2019-09-10.
CIK 0001586835
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XLRN | 86,986 | $15.5M |
Shares reported on the most recent Form 4, priced at the 2019-09-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLRN | SELL · 10b5-1 | 2019-09-10 | 2019-09-10 | $45.24 | $153K | -5.7% | -16.1% | +9.2% |
| XLRN | SELL · 10b5-1 | 2019-04-09 | 2019-04-11 | $44.64 | $162K | -7.1% | -6.9% | -5.0% |
| XLRN | SELL | 2019-01-02 | 2019-01-04 | $42.94 | $249K | +2.4% | +3.4% | +10.7% |
| XLRN | SELL · 10b5-1 | 2018-04-03 | 2018-04-04 | $38.41 | $46K | -2.3% | -6.2% | +22.7% |
| XLRN | SELL · 10b5-1 | 2018-01-02 | 2018-01-04 | $42.41 | $182K | +4.6% | -9.5% | -10.8% |
| XLRN | SELL · 10b5-1 | 2017-09-12 | 2017-09-14 | $38.42 | $196K | -11.5% | -4.2% | -5.1% |
| XLRN | SELL · 10b5-1 | 2017-08-08 | 2017-08-09 | $35.41 | $463K | -7.0% | +7.8% | +0.1% |
| XLRN | SELL · 10b5-1 | 2017-07-05 | 2017-07-07 | $32.00 | $30K | -5.2% | +8.5% | +17.8% |
| XLRN | SELL · 10b5-1 | 2017-01-04 | 2017-01-06 | $27.46 | $55K | -9.2% | -11.0% | -3.4% |
| XLRN | SELL · 10b5-1 | 2016-10-06 | 2016-10-11 | $33.92 | $1.8M | -13.3% | +8.0% | -21.2% |
| XLRN | SELL · 10b5-1 | 2015-09-15 | 2015-09-16 | $35.00 | $1.2M | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-03-04 | 2015-03-06 | $40.91 | $225K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-02-02 | 2015-02-04 | $38.68 | $213K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-01-12 | 2015-01-13 | $40.80 | $61K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-01-02 | 2015-01-05 | $38.46 | $154K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-12-01 | 2014-12-02 | $35.88 | $144K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-11-12 | 2014-11-14 | $34.53 | $552K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-09-30 | 2014-10-01 | $29.89 | $329K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-08-14 | 2014-08-15 | $29.97 | $270K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-07-01 | 2014-07-02 | $34.10 | $68K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-06-20 | 2014-06-24 | $35.00 | $245K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-06-02 | 2014-06-04 | $29.72 | $59K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-05-19 | 2014-05-21 | $31.36 | $282K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-04-22 | 2014-04-24 | $35.86 | $72K | -30.5% | -6.3% | -6.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.